6-Bromohexanoic acid structure
|
Common Name | 6-Bromohexanoic acid | ||
---|---|---|---|---|
CAS Number | 4224-70-8 | Molecular Weight | 195.054 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 279.2±0.0 °C at 760 mmHg | |
Molecular Formula | C6H11BrO2 | Melting Point | 32-34 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 67.8±0.0 °C | |
Symbol |
GHS05 |
Signal Word | Danger |
Name | 6-bromohexanoic acid |
---|---|
Synonym | More Synonyms |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 279.2±0.0 °C at 760 mmHg |
Melting Point | 32-34 °C(lit.) |
Molecular Formula | C6H11BrO2 |
Molecular Weight | 195.054 |
Flash Point | 67.8±0.0 °C |
Exact Mass | 193.994232 |
PSA | 37.30000 |
LogP | 1.70 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.490 |
Storage condition | 2-8°C |
Water Solubility | methanol: 0.1 g/mL, clear, colorless |
Symbol |
GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | C:Corrosive |
Risk Phrases | R34 |
Safety Phrases | S26-S36/37/39-S45-S28A |
RIDADR | UN 3261 8/PG 2 |
WGK Germany | 3 |
Packaging Group | III |
Hazard Class | 8 |
HS Code | 29159080 |
Precursor 10 | |
---|---|
DownStream 10 | |
HS Code | 2915900090 |
---|---|
Summary | 2915900090 other saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:5.5% General tariff:30.0% |
A Combination of Targeted Sunitinib Liposomes and Targeted Vinorelbine Liposomes for Treating Invasive Breast Cancer.
J. Biomed. Nanotechnol. 11 , 1568-82, (2015) Regular chemotherapy cannot eradicate invasive breast cancer cells and the residual cancer cells will form vasculogenic mimicry (VM) channels under hypoxic conditions to provide nutrients for cancer m... |
|
Mitochondria apoptosis pathway synergistically activated by hierarchical targeted nanoparticles co-delivering siRNA and lonidamine.
Biomaterials 61 , 178-89, (2015) The mitochondria-mediated apoptosis pathway is an effective option for cancer therapy due to the presence of cell-suicide weapons in mitochondria. However, anti-apoptotic proteins that are over-expres... |
|
Shared Ligands Between Organic Anion Transporters (OAT1 and OAT6) and Odorant Receptors.
Drug Metab. Dispos. 43 , 1855-63, (2015) The multispecific organic anion drug transporters OAT6 (SLC22A20) and OAT1 (SLC22A6) are expressed in nasal epithelial cells and both can bind odorants. Sequence analysis of OAT6 revealed an evolution... |
6-bromo hexanoic acid |
EINECS 224-176-5 |
Hexanoic acid,6-bromo |
6-Bromocaproic acid |
bromopentylcarboxylic acid |
6-Bromo-n-caproic acid |
Hexanoic acid, 6-bromo- |
1-bromo-5-carboxypentane |
6-Bromohexanoic acid |
MFCD00004422 |